Whan In Pharm Co.,Ltd. (KRX: 016580)

Whan In Pharm Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	38,166	45,366	36,776	64,056	36,074	17,982
Short-Term Investments	441	15,164	12,791	22,966	11,944	21,000
Trading Asset Securities	12,923	17,927	37,725	58,940	68,938	72,809
Cash & Short-Term Investments	51,531	78,457	87,292	145,962	116,956	111,791
Cash Growth	-31.12%	-10.12%	-40.20%	24.80%	4.62%	19.92%
Accounts Receivable	73,101	74,526	68,242	61,876	63,042	63,433
Other Receivables	7,124	4,340	4,021	1,243	998.83	1,033
Receivables	80,269	78,947	72,326	63,201	64,106	64,555
Inventory	66,555	54,058	37,060	32,745	32,764	28,218
Prepaid Expenses	620.56	501.07	426.78	334.39	185.05	137.91
Other Current Assets	70.2	138.51	317.02	169.72	343.61	275.51
Total Current Assets	199,045	212,101	197,422	242,412	214,355	204,977
Property, Plant & Equipment	149,937	131,211	109,854	46,869	45,822	39,697
Long-Term Investments	33,787	19,163	23,901	26,193	30,945	21,214
Other Intangible Assets	6,469	5,382	3,176	2,969	2,988	3,115
Long-Term Deferred Tax Assets	835.03	171.91	-	-	-	-
Other Long-Term Assets	32,787	33,159	35,002	34,715	35,431	35,858
Total Assets	422,937	401,227	369,375	353,189	329,560	304,885
Accounts Payable	22,628	18,071	11,966	9,422	8,865	9,177
Accrued Expenses	2,609	3,224	2,473	4,171	2,246	2,013
Current Portion of Leases	324.63	324.97	186.32	415.86	546.59	426.51
Current Income Taxes Payable	4,072	2,683	3,330	5,571	5,696	5,040
Other Current Liabilities	14,210	15,725	13,796	11,320	9,372	8,087
Total Current Liabilities	43,843	40,028	31,750	30,900	26,725	24,743
Long-Term Leases	182.01	307.06	63.62	1,305	1,643	1,134
Long-Term Deferred Tax Liabilities	-	-	368.34	1,098	2,011	1,228
Other Long-Term Liabilities	4,755	2,684	3,264	2,660	2,578	3,318
Total Liabilities	48,781	43,019	35,446	35,963	32,957	30,424
Common Stock	9,700	9,700	9,700	9,700	9,700	9,700
Additional Paid-In Capital	21,062	21,062	20,817	21,135	21,135	21,135
Retained Earnings	355,276	339,984	314,790	295,449	273,163	254,079
Treasury Stock	-9,669	-9,669	-9,669	-9,669	-9,669	-9,669
Comprehensive Income & Other	-2,213	-2,870	-2,126	324.92	1,787	-1,468
Total Common Equity	374,156	358,207	333,511	316,939	296,115	273,777
Minority Interest	-	-	416.75	286.26	487.35	683.84
Shareholders' Equity	374,156	358,207	333,928	317,226	296,602	274,461
Total Liabilities & Equity	422,937	401,227	369,375	353,189	329,560	304,885
Total Debt	506.64	632.03	249.94	1,721	2,190	1,561
Net Cash (Debt)	51,024	77,825	87,042	144,241	114,766	110,230
Net Cash Growth	-31.29%	-10.59%	-39.66%	25.68%	4.12%	18.25%
Net Cash Per Share	3342.09	5097.57	5701.29	9447.84	7517.24	7220.10
Filing Date Shares Outstanding	15.27	15.27	15.27	15.27	15.27	15.27
Total Common Shares Outstanding	15.27	15.27	15.27	15.27	15.27	15.27
Working Capital	155,202	172,074	165,671	211,512	187,630	180,233
Book Value Per Share	24507.41	23462.75	21845.15	20759.68	19395.66	17932.54
Tangible Book Value	367,687	352,826	330,335	313,970	293,127	270,663
Tangible Book Value Per Share	24083.65	23110.24	21637.11	20565.20	19199.97	17728.52
Land	49,572	49,572	49,726	13,536	13,536	13,536
Buildings	70,906	40,938	35,821	24,194	24,032	24,058
Machinery	24,288	22,094	18,653	10,919	9,552	9,075
Construction In Progress	2,495	18,876	7,590	4,610	4,810	20

Source: S&P Capital IQ. Standard template. Financial Sources.